Windtree Therapeutics - Warrants (25/03/2026) (WINT+) Q3 2012 Earnings

8NovExpected
Q4 2011
Q1 2012
Q2 2012
Q3 2012
-15,540
-10,693
-5,846
-999

Details

Expected EPS
-9520
Actual EPS
-13020
Surprise EPS
-3,500
Surprise Percent
+36.76%

Description

Windtree Therapeutics - Warrants (25/03/2026) (WINT+) has reported earnings of -13020 per share for Q3 2012.

0 Comments

Share your thoughts